APA (7th ed.) Citation

Yan, Z., Zhong, Z., Shi, C., Feng, M., Feng, X., & Liu, T. The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yan, Zhideng, Zhihui Zhong, Chuanke Shi, Muyin Feng, Xiaoqiang Feng, and Tong Liu. The Prognostic Marker KRT81 Is Involved in Suppressing CD8 + T Cells and Predicts Immunotherapy Response for Triple-negative Breast Cancer. Taylor & Francis Group.

MLA (9th ed.) Citation

Yan, Zhideng, et al. The Prognostic Marker KRT81 Is Involved in Suppressing CD8 + T Cells and Predicts Immunotherapy Response for Triple-negative Breast Cancer. Taylor & Francis Group.